DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L.
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
The New England journal of medicine 2001; 344: 783-792
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.